Clovis Oncology, Inc. (NASDAQ:CLVS)- Bullish Movers Gaining Investors Attention: Horizon Pharma plc (NASDAQ:HZNP)

Clovis Oncology, Inc. (NASDAQ:CLVS) [Trend Analysis] luring active investment momentum, shares a gain 8.65% to $46.20. The total volume of 4.41 Million shares held in the session was surprisingly higher than its average volume of 2723.53 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to …

Read More »